Motley Fool Asset Management LLC Has $2.59 Million Stock Holdings in Penumbra, Inc. (NYSE:PEN)

Motley Fool Asset Management LLC grew its stake in shares of Penumbra, Inc. (NYSE:PEN - Free Report) by 10.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,897 shares of the company's stock after purchasing an additional 1,020 shares during the period. Motley Fool Asset Management LLC's holdings in Penumbra were worth $2,588,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of PEN. UMB Bank n.a. raised its holdings in Penumbra by 57.4% during the 4th quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $46,000 after buying an additional 70 shares during the period. Huntington National Bank boosted its holdings in shares of Penumbra by 138.7% in the fourth quarter. Huntington National Bank now owns 265 shares of the company's stock worth $63,000 after buying an additional 154 shares during the period. Mather Group LLC. increased its position in shares of Penumbra by 208.0% in the fourth quarter. Mather Group LLC. now owns 308 shares of the company's stock worth $73,000 after acquiring an additional 208 shares in the last quarter. Jones Financial Companies Lllp raised its holdings in shares of Penumbra by 25.0% during the fourth quarter. Jones Financial Companies Lllp now owns 375 shares of the company's stock valued at $89,000 after acquiring an additional 75 shares during the period. Finally, GAMMA Investing LLC lifted its position in shares of Penumbra by 160.8% in the 4th quarter. GAMMA Investing LLC now owns 446 shares of the company's stock valued at $106,000 after acquiring an additional 275 shares in the last quarter. Institutional investors and hedge funds own 88.88% of the company's stock.

Insider Activity at Penumbra

In other news, Director Thomas Wilder sold 360 shares of the company's stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $266.93, for a total transaction of $96,094.80. Following the completion of the transaction, the director now directly owns 4,692 shares in the company, valued at $1,252,435.56. The trade was a 7.13 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Johanna Roberts sold 600 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $287.43, for a total transaction of $172,458.00. Following the completion of the sale, the executive vice president now owns 66,539 shares in the company, valued at approximately $19,125,304.77. The trade was a 0.89 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 111,236 shares of company stock worth $31,222,390. 5.00% of the stock is owned by insiders.

Penumbra Stock Up 7.8 %

NYSE:PEN traded up $19.89 during trading hours on Wednesday, reaching $275.71. The company's stock had a trading volume of 685,564 shares, compared to its average volume of 409,302. Penumbra, Inc. has a one year low of $148.00 and a one year high of $310.00. The business's 50-day moving average is $274.05 and its 200-day moving average is $247.67. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.01 and a quick ratio of 3.25. The company has a market cap of $10.62 billion, a price-to-earnings ratio of 810.91, a price-to-earnings-growth ratio of 2.83 and a beta of 0.56.

Penumbra (NYSE:PEN - Get Free Report) last issued its quarterly earnings data on Tuesday, February 18th. The company reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.88 by $0.09. Penumbra had a return on equity of 9.74% and a net margin of 1.17%. The business had revenue of $315.52 million for the quarter, compared to analyst estimates of $311.63 million. Equities research analysts predict that Penumbra, Inc. will post 3.67 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on PEN shares. Needham & Company LLC reiterated a "hold" rating on shares of Penumbra in a research report on Wednesday, February 19th. JPMorgan Chase & Co. upped their price target on Penumbra from $230.00 to $285.00 and gave the company an "overweight" rating in a research report on Wednesday, February 19th. Robert W. Baird increased their price objective on Penumbra from $305.00 to $328.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 19th. Wells Fargo & Company lifted their target price on Penumbra from $275.00 to $305.00 and gave the company an "overweight" rating in a research note on Wednesday, February 19th. Finally, Truist Financial increased their price target on shares of Penumbra from $285.00 to $325.00 and gave the stock a "buy" rating in a research report on Wednesday, February 19th. Four equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $294.47.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.